1. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21(17):3357–3365
2. McGuire WL (1980) An update on estrogen and progesterone receptors in prognosis for primary and advanced breast cancer. In: Iacobelli S et al (eds) Hormones and cancer. Raven Press, New York
3. Group EBCTC (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351(9114):1451–1467
4. Crowe JP Jr, Gordon NH, Hubay CA, Shenk RR, Zollinger RM, Brumberg DJ, McGuire WL, Shuck JM (1991) Estrogen receptor determination and long term survival of patients with carcinoma of the breast. Surg Gynecol Obstet 173(4):273–278
5. Maynard PV, Blamey RW, Elston CW, Haybittle JL, Griffiths K (1978) Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res 38(11 Pt 2):4292–4295